Literature DB >> 30713830

Novel insights into the oncogenic function of the SMYD3 lysine methyltransferase.

Pawel K Mazur1,2, Or Gozani3, Julien Sage1,2, Nicolas Reynoird4.   

Abstract

Entities:  

Year:  2016        PMID： 30713830      PMCID： PMC6358167          DOI： 10.21037/tcr.2016.06.26

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN： 2218-676X            Impact factor:   1.241


× No keyword cloud information.
  20 in total

1.  SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription.

Authors:  Cheng Liu; Chang Wang; Kun Wang; Li Liu; Qi Shen; Keqiang Yan; Xiaoqing Sun; Jie Chen; Jikai Liu; Hongbo Ren; Hainan Liu; Zhonghua Xu; Sanyuan Hu; Dawei Xu; Yidong Fan
Journal:  J Natl Cancer Inst       Date:  2013-10-30       Impact factor: 13.506

2.  Repression of p53 activity by Smyd2-mediated methylation.

Authors:  Jing Huang; Laura Perez-Burgos; Brandon J Placek; Roopsha Sengupta; Mario Richter; Jean A Dorsey; Stefan Kubicek; Susanne Opravil; Thomas Jenuwein; Shelley L Berger
Journal:  Nature       Date:  2006-11-15       Impact factor: 49.962

3.  The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.

Authors:  Masaki Kunizaki; Ryuji Hamamoto; Fabio Pittella Silva; Kiyoshi Yamaguchi; Takeshi Nagayasu; Masabumi Shibuya; Yusuke Nakamura; Yoichi Furukawa
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

4.  SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.

Authors:  Ryuji Hamamoto; Yoichi Furukawa; Masashi Morita; Yuko Iimura; Fabio Pittella Silva; Meihua Li; Ryuichiro Yagyu; Yusuke Nakamura
Journal:  Nat Cell Biol       Date:  2004-07-04       Impact factor: 28.824

5.  The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.

Authors:  Cheng Liu; Xiaolei Fang; Zheng Ge; Marit Jalink; Satoru Kyo; Magnus Björkholm; Astrid Gruber; Jan Sjöberg; Dawei Xu
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

6.  Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription.

Authors:  Hyunjung Kim; Kyu Heo; Jeong Hoon Kim; Kyunghwan Kim; Jongkyu Choi; Woojin An
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

7.  SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.

Authors:  Alicia M Cock-Rada; Souhila Medjkane; Natacha Janski; Nadhir Yousfi; Martine Perichon; Marie Chaussepied; Johanna Chluba; Gordon Langsley; Jonathan B Weitzman
Journal:  Cancer Res       Date:  2011-12-22       Impact factor: 12.701

8.  Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation.

Authors:  Glenn S Van Aller; Nicolas Reynoird; Olena Barbash; Michael Huddleston; Shichong Liu; Anne-Flore Zmoos; Patrick McDevitt; Robert Sinnamon; BaoChau Le; Gloria Mas; Roland Annan; Julien Sage; Benjamin A Garcia; Peter J Tummino; Or Gozani; Ryan G Kruger
Journal:  Epigenetics       Date:  2012-04-01       Impact factor: 4.528

9.  Smyd3 is required for the development of cardiac and skeletal muscle in zebrafish.

Authors:  Tomoaki Fujii; Shin-ichiro Tsunesumi; Kiyoshi Yamaguchi; Sumiko Watanabe; Yoichi Furukawa
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

10.  Methylation of H4 lysines 5, 8 and 12 by yeast Set5 calibrates chromatin stress responses.

Authors:  Erin M Green; Gloria Mas; Nicolas L Young; Benjamin A Garcia; Or Gozani
Journal:  Nat Struct Mol Biol       Date:  2012-02-19       Impact factor: 15.369
View more
  1 in total

1.  SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

Authors:  Valentina Lukinović; Simone Hausmann; Gael S Roth; Clement Oyeniran; Tanveer Ahmad; Ning Tsao; Joshua R Brickner; Alexandre G Casanova; Florent Chuffart; Ana Morales Benitez; Jessica Vayr; Rebecca Rodell; Marianne Tardif; Pascal W T C Jansen; Yohann Couté; Michiel Vermeulen; Pierre Hainaut; Pawel K Mazur; Nima Mosammaparast; Nicolas Reynoird
Journal:  Cancer Discov       Date:  2022-09-02       Impact factor: 38.272
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.